Northera 300mg Capsules
Overview
What is this medicine?
How to Use This Medicine
To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely.
When taking your medication:
- Swallow the tablet whole.
- Do not chew, open, or crush the tablet.
- You can take your medication with or without food, but it's essential to take it the same way each time. Choose to either always take it with food or always take it on an empty stomach.
- Make sure to take your last dose of the day at least 3 hours before bedtime. This helps reduce the risk of high blood pressure during sleep.
Storing and Disposing of Your Medication
To maintain the effectiveness and safety of your medication:
- Store it at room temperature in a dry place.
- Avoid storing your medication in a bathroom.
- Keep all medications in a safe location.
- Ensure that all medications are out of the reach of children and pets.
What to Do If You Miss a Dose
If you miss a dose, skip it and return to your regular dosing schedule.
- Do not take two doses at the same time.
- Do not take extra doses to make up for the missed dose.
Lifestyle & Tips
- Take exactly as prescribed by your doctor.
- Do not take the last dose of the day within 3 hours of bedtime to reduce the risk of high blood pressure while lying down (supine hypertension).
- Elevate the head of your bed while sleeping to help prevent supine hypertension.
- Avoid sudden changes in position (e.g., standing up too quickly) even with medication.
- Stay well-hydrated unless otherwise advised by your doctor.
- Avoid alcohol, as it can worsen orthostatic hypotension.
- Inform your doctor about all other medications you are taking, including over-the-counter drugs and supplements.
Available Forms & Alternatives
Available Strengths:
Generic Alternatives:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood pressure, including:
+ Severe headache
+ Dizziness
+ Fainting
+ Changes in eyesight
Signs of a urinary tract infection (UTI), such as:
+ Blood in the urine
+ Burning or pain while urinating
+ Frequent or urgent need to urinate
+ Fever
+ Lower stomach pain
+ Pelvic pain
Weakness on one side of the body
Trouble speaking or thinking
Changes in balance
Drooping on one side of the face
Blurred vision
Falls
Neuroleptic malignant syndrome (NMS), a rare but potentially deadly condition, characterized by:
+ Fever
+ Muscle cramps or stiffness
+ Dizziness
+ Severe headache
+ Confusion
+ Changes in thinking
+ Rapid heartbeat
+ Abnormal heartbeat
+ Excessive sweating
Other Possible Side Effects
Most people experience no side effects or only mild ones. However, if you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention:
Dizziness
Headache
* Upset stomach
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe headache
- Blurred vision
- Chest pain
- Pounding in the ears
- Shortness of breath
- Irregular heartbeat (palpitations)
- Nausea or vomiting
- Dizziness or lightheadedness (if worsening or not improving)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
If you are currently taking any of the following medications:
+ Isocarboxazid, phenelzine, or tranylcypromine
+ Linezolid or methylene blue
* If you are breastfeeding. Please note that you should not breastfeed while taking this medication.
This list is not exhaustive, and it is crucial to discuss all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist. They will help you determine if it is safe to take this medication with your existing medications and health conditions.
Remember, do not start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
To monitor your condition, follow the instructions provided by your healthcare provider for checking your blood pressure.
If you have a known allergy to tartrazine (also referred to as FD&C Yellow No. 5), consult with your doctor before taking this medication, as some formulations may contain this ingredient.
Pre-existing heart conditions, such as abnormal heartbeat and heart failure, may worsen with the use of this drug. If you have a history of heart problems, discuss the potential risks with your doctor. Immediately contact your doctor if you experience any of the following symptoms: abnormal heartbeat, shortness of breath, significant weight gain, or new or worsening swelling in your arms or legs.
If you are pregnant or planning to become pregnant, consult with your doctor to discuss the benefits and risks associated with using this medication during pregnancy.
Overdose Information
Overdose Symptoms:
- Excessive increase in blood pressure (hypertensive crisis)
- Headache
- Palpitations
- Bradycardia (reflex)
- Chest pain
- Blurred vision
- Nausea
- Vomiting
- Anxiety
- Tremor
What to Do:
Seek immediate medical attention. Call 911 or your local emergency number. In the US, you can also call Poison Control at 1-800-222-1222. Treatment is supportive and symptomatic, focusing on managing blood pressure and cardiovascular effects.
Drug Interactions
Major Interactions
- Monoamine Oxidase Inhibitors (MAOIs) (e.g., phenelzine, selegiline, linezolid): May lead to hypertensive crisis due to inhibition of norepinephrine metabolism.
- Tricyclic Antidepressants (TCAs) (e.g., amitriptyline, imipramine): May potentiate the pressor effect of droxidopa by inhibiting norepinephrine reuptake.
- Other sympathomimetic agents (e.g., pseudoephedrine, phenylephrine, other alpha/beta agonists): Increased risk of supine hypertension and other cardiovascular adverse effects.
Moderate Interactions
- Beta-blockers (e.g., propranolol, metoprolol): May reduce the efficacy of droxidopa or lead to unopposed alpha-adrenergic effects.
- Antihypertensive agents: May have additive effects, requiring dose adjustment of antihypertensives.
- DOPA decarboxylase inhibitors (e.g., carbidopa, benserazide): May inhibit the conversion of droxidopa to norepinephrine, reducing its efficacy. Co-administration is generally not recommended unless specifically indicated for other conditions and monitored closely.
Minor Interactions
- Not typically listed in detail for minor interactions.
Monitoring
Baseline Monitoring
Rationale: To establish baseline orthostatic hypotension severity and identify pre-existing supine hypertension.
Timing: Prior to initiation of therapy.
Rationale: To assess baseline cardiovascular status.
Timing: Prior to initiation of therapy.
Rationale: To quantify baseline symptom severity and guide treatment goals.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Regularly, especially during dose titration (e.g., daily or every other day) and periodically thereafter (e.g., weekly to monthly).
Target: Standing SBP increase without excessive supine hypertension (e.g., supine SBP <180-200 mmHg).
Action Threshold: If supine SBP consistently >180-200 mmHg, consider dose reduction or discontinuation. If standing BP remains low, consider further titration.
Frequency: During dose titration and periodically thereafter.
Target: Within normal limits or patient's baseline.
Action Threshold: Significant tachycardia or bradycardia may warrant investigation.
Frequency: Regularly during treatment.
Target: Improvement or resolution of symptoms.
Action Threshold: Lack of improvement or worsening symptoms may indicate need for dose adjustment or alternative therapy.
Frequency: Regularly, especially after dose increases.
Target: Absence of symptoms.
Action Threshold: Presence of symptoms warrants immediate assessment of supine BP and potential dose reduction.
Symptom Monitoring
- Dizziness
- Lightheadedness
- Fainting (syncope)
- Falls
- Fatigue
- Headache (especially when lying down)
- Blurred vision (especially when lying down)
- Chest pain (especially when lying down)
- Palpitations
- Nausea
Special Patient Groups
Pregnancy
Category C. There are no adequate and well-controlled studies of droxidopa in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Trimester-Specific Risks:
Lactation
It is not known whether droxidopa or its metabolites are excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Pediatric Use
The safety and effectiveness of droxidopa in pediatric patients have not been established.
Geriatric Use
No overall differences in safety or effectiveness were observed between elderly subjects and younger subjects, but greater sensitivity of some older individuals cannot be ruled out. Elderly patients may be at increased risk for supine hypertension and should be monitored closely.
Clinical Information
Clinical Pearls
- Droxidopa is a prodrug that requires DOPA decarboxylase for activation; therefore, co-administration with DOPA decarboxylase inhibitors (e.g., carbidopa) may reduce its efficacy.
- The most significant adverse effect is supine hypertension. Emphasize the importance of taking the last dose at least 3 hours before bedtime and elevating the head of the bed.
- Blood pressure monitoring (both supine and standing) is crucial, especially during dose titration.
- Patients should be advised to report symptoms of supine hypertension (e.g., severe headache, blurred vision, chest pain) immediately.
- Titrate the dose slowly and individually based on patient response and tolerability, balancing symptomatic improvement with the risk of supine hypertension.
Alternative Therapies
- Midodrine (another alpha-1 adrenergic agonist)
- Fludrocortisone (mineralocorticoid)
- Pyridostigmine (cholinesterase inhibitor, off-label for nOH)
- Non-pharmacological interventions (e.g., increased fluid and salt intake, compression stockings, physical counter-maneuvers, small frequent meals, avoiding large carbohydrate meals, avoiding prolonged standing)